a number of statistically significant markers, but cd19 is best. Third study confirms trend. Not different by stage i.e. stage independent, mild, mod, severe. New marker identified. multivariate algorithms ongoing for new marker. V1 and V2 both good. They're going to likely roll with V1.

Gtown assay. Always a reason behind "delays"... real science and business